DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Payne HA. et al.
Apalutamide for non-metastatic castration resistant prostate cancer (NMCRPC): a comparison of real-life experience from an international named patient program (NPP) vs the prior phase III clinical study. ESMO 2020, Abstract & Poster 630P.
Ann Oncol 2020;
30 (Suppl. 04) S520
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.